Freestone Grove Partners LP
Position in ANIP — Ani Pharmaceuticals Inc
CIK 2007591
San Francisco, CA
Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,388,262
-$11,162,025 QoQ
Shares Held
101,332
-60.1% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#55
of 303 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Freestone Grove Partners LP holds $100,700,353 across 12 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
2,170,681 | $53,420,459 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
604,053 | $20,465,315 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
316,398 | $14,715,670 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
101,332 | $8,388,262 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
44,493 | $1,610,646 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
18,079 | $854,594 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,207 | $653,988 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
4,615 | $295,129 |
All Filings in ANIP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,388,262 | 101,332 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,550,287 | 254,230 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,139,144 | 141,109 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,810,654 | 30,684 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,737,713 | 195,214 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $267,599 | 3,997 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $258,655 | 4,679 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||